Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Wag! Group ( (PET) ) just unveiled an update.
On July 14, 2025, Wag Labs, Inc. and Wag! Group Co. completed the sale of their veterinary e-prescription software, Furscription, to MWI Veterinary Supply Co. for $5 million. The sale proceeds will be used to partially repay the company’s debt to Retriever LLC. Despite this transaction, Wag! Group continues to face financial challenges and is exploring strategic alternatives to meet its remaining obligations, with the possibility of seeking bankruptcy protection if necessary.
The most recent analyst rating on (PET) stock is a Buy with a $3.50 price target. To see the full list of analyst forecasts on Wag! Group stock, see the PET Stock Forecast page.
Spark’s Take on PET Stock
According to Spark, TipRanks’ AI Analyst, PET is a Neutral.
The overall score reflects significant financial challenges, including declining revenues and high debt, offset slightly by technical indicators and cost management achievements. The looming bankruptcy risk due to financing issues heavily impacts the evaluation.
To see Spark’s full report on PET stock, click here.
More about Wag! Group
Wag! Group is involved in the industry of veterinary e-prescriptions, providing software and business solutions for managing electronic prescriptions in the veterinary field.
Average Trading Volume: 9,641,619
Technical Sentiment Signal: Sell
Current Market Cap: $8.21M
For an in-depth examination of PET stock, go to TipRanks’ Overview page.